Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06647277
PHASE1
Fecal MicrobiotaTransplant for the Treatment of Parkinson's Disease
Sponsor: ProgenaBiome
View on ClinicalTrials.gov
Summary
FMT may significantly improve quality of life and Parkinson Disease (PD) symptom severity measurements. We hypothesize that gut microbial dysbiosis is a major contributing factor in Parkinson's disease.
Official title: An Open-Label Phase I Clinical Trial of Vancomycin Followed by Fecal Microbiota Transplant for the Treatment of Parkinson's Disease
Key Details
Gender
All
Age Range
18 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
10
Start Date
2026-07
Completion Date
2027-12
Last Updated
2025-06-26
Healthy Volunteers
No
Conditions
Interventions
COMBINATION_PRODUCT
Fecal Microbiota Transplant
Fecal Microbiota Transplant
Locations (1)
Sabine Hazan
Ventura, California, United States